Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells
Article in Molecular Metabolism (July 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Targeted lipidomics uncovers oxylipin perturbations and potential circulation biomarkers in Bietti’s crystalline dystrophy
Article in Graefe's Archive for Clinical and Experimental Ophthalmology (July 2024)
Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells.
Preprint in Research Square (January 2024)